2025-02-012026-01-312026-01-31false04944299ALAN CHALMERS (CHEMISTS) LIMITED2026-10-21falseiso4217:GBPxbrli:pure049442992025-01-31049442992026-01-31049442992025-02-012026-01-31049442992023-12-31049442992025-01-31049442992024-01-012025-01-3104944299bus:SmallEntities2025-02-012026-01-3104944299bus:AuditExempt-NoAccountantsReport2025-02-012026-01-3104944299bus:FullAccounts2025-02-012026-01-3104944299bus:PrivateLimitedCompanyLtd2025-02-012026-01-3104944299core:WithinOneYear2026-01-3104944299core:AfterOneYear2026-01-3104944299core:WithinOneYear2025-01-3104944299core:AfterOneYear2025-01-3104944299core:ShareCapital2026-01-3104944299core:SharePremium2026-01-3104944299core:RevaluationReserve2026-01-3104944299core:OtherReservesSubtotal2026-01-3104944299core:RetainedEarningsAccumulatedLosses2026-01-3104944299core:ShareCapital2025-01-3104944299core:SharePremium2025-01-3104944299core:RevaluationReserve2025-01-3104944299core:OtherReservesSubtotal2025-01-3104944299core:RetainedEarningsAccumulatedLosses2025-01-3104944299core:LandBuildings2026-01-3104944299core:PlantMachinery2026-01-3104944299core:Vehicles2026-01-3104944299core:FurnitureFittings2026-01-3104944299core:OfficeEquipment2026-01-3104944299core:NetGoodwill2026-01-3104944299core:IntangibleAssetsOtherThanGoodwill2026-01-3104944299core:ListedExchangeTraded2026-01-3104944299core:UnlistedNon-exchangeTraded2026-01-3104944299core:LandBuildings2025-01-3104944299core:PlantMachinery2025-01-3104944299core:Vehicles2025-01-3104944299core:FurnitureFittings2025-01-3104944299core:OfficeEquipment2025-01-3104944299core:NetGoodwill2025-01-3104944299core:IntangibleAssetsOtherThanGoodwill2025-01-3104944299core:ListedExchangeTraded2025-01-3104944299core:UnlistedNon-exchangeTraded2025-01-3104944299core:LandBuildings2025-02-012026-01-3104944299core:PlantMachinery2025-02-012026-01-3104944299core:Vehicles2025-02-012026-01-3104944299core:FurnitureFittings2025-02-012026-01-3104944299core:OfficeEquipment2025-02-012026-01-3104944299core:NetGoodwill2025-02-012026-01-3104944299core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3104944299core:ListedExchangeTraded2025-02-012026-01-3104944299core:UnlistedNon-exchangeTraded2025-02-012026-01-3104944299core:MoreThanFiveYears2025-02-012026-01-3104944299core:Non-currentFinancialInstruments2026-01-3104944299core:Non-currentFinancialInstruments2025-01-3104944299dpl:CostSales2025-02-012026-01-3104944299dpl:DistributionCosts2025-02-012026-01-3104944299core:LandBuildings2025-02-012026-01-3104944299core:PlantMachinery2025-02-012026-01-3104944299core:Vehicles2025-02-012026-01-3104944299core:FurnitureFittings2025-02-012026-01-3104944299core:OfficeEquipment2025-02-012026-01-3104944299dpl:AdministrativeExpenses2025-02-012026-01-3104944299core:NetGoodwill2025-02-012026-01-3104944299core:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3104944299dpl:GroupUndertakings2025-02-012026-01-3104944299dpl:ParticipatingInterests2025-02-012026-01-3104944299dpl:GroupUndertakingscore:ListedExchangeTraded2025-02-012026-01-3104944299core:ListedExchangeTraded2025-02-012026-01-3104944299dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-02-012026-01-3104944299core:UnlistedNon-exchangeTraded2025-02-012026-01-3104944299dpl:CostSales2024-01-012025-01-3104944299dpl:DistributionCosts2024-01-012025-01-3104944299core:LandBuildings2024-01-012025-01-3104944299core:PlantMachinery2024-01-012025-01-3104944299core:Vehicles2024-01-012025-01-3104944299core:FurnitureFittings2024-01-012025-01-3104944299core:OfficeEquipment2024-01-012025-01-3104944299dpl:AdministrativeExpenses2024-01-012025-01-3104944299core:NetGoodwill2024-01-012025-01-3104944299core:IntangibleAssetsOtherThanGoodwill2024-01-012025-01-3104944299dpl:GroupUndertakings2024-01-012025-01-3104944299dpl:ParticipatingInterests2024-01-012025-01-3104944299dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012025-01-3104944299core:ListedExchangeTraded2024-01-012025-01-3104944299dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012025-01-3104944299core:UnlistedNon-exchangeTraded2024-01-012025-01-3104944299core:NetGoodwill2026-01-3104944299core:IntangibleAssetsOtherThanGoodwill2026-01-3104944299core:LandBuildings2026-01-3104944299core:PlantMachinery2026-01-3104944299core:Vehicles2026-01-3104944299core:FurnitureFittings2026-01-3104944299core:OfficeEquipment2026-01-3104944299core:AfterOneYear2026-01-3104944299core:WithinOneYear2026-01-3104944299core:ListedExchangeTraded2026-01-3104944299core:UnlistedNon-exchangeTraded2026-01-3104944299core:ShareCapital2026-01-3104944299core:SharePremium2026-01-3104944299core:RevaluationReserve2026-01-3104944299core:OtherReservesSubtotal2026-01-3104944299core:RetainedEarningsAccumulatedLosses2026-01-3104944299core:NetGoodwill2025-01-3104944299core:IntangibleAssetsOtherThanGoodwill2025-01-3104944299core:LandBuildings2025-01-3104944299core:PlantMachinery2025-01-3104944299core:Vehicles2025-01-3104944299core:FurnitureFittings2025-01-3104944299core:OfficeEquipment2025-01-3104944299core:AfterOneYear2025-01-3104944299core:WithinOneYear2025-01-3104944299core:ListedExchangeTraded2025-01-3104944299core:UnlistedNon-exchangeTraded2025-01-3104944299core:ShareCapital2025-01-3104944299core:SharePremium2025-01-3104944299core:RevaluationReserve2025-01-3104944299core:OtherReservesSubtotal2025-01-3104944299core:RetainedEarningsAccumulatedLosses2025-01-3104944299core:NetGoodwill2023-12-3104944299core:IntangibleAssetsOtherThanGoodwill2023-12-3104944299core:LandBuildings2023-12-3104944299core:PlantMachinery2023-12-3104944299core:Vehicles2023-12-3104944299core:FurnitureFittings2023-12-3104944299core:OfficeEquipment2023-12-3104944299core:AfterOneYear2023-12-3104944299core:WithinOneYear2023-12-3104944299core:ListedExchangeTraded2023-12-3104944299core:UnlistedNon-exchangeTraded2023-12-3104944299core:ShareCapital2023-12-3104944299core:SharePremium2023-12-3104944299core:RevaluationReserve2023-12-3104944299core:OtherReservesSubtotal2023-12-3104944299core:RetainedEarningsAccumulatedLosses2023-12-3104944299core:AfterOneYear2025-02-012026-01-3104944299core:WithinOneYear2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:CostValuation2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-012026-01-3104944299core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3104944299core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-3104944299core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3104944299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-3104944299core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-3104944299core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-3104944299core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-01-3104944299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-3104944299core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-3104944299core:Non-currentFinancialInstrumentscore:CostValuation2025-01-3104944299core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-3104944299core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-3104944299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-3104944299core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-3104944299core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-3104944299core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-3104944299core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-3104944299core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-3104944299bus:Director12025-02-012026-01-3104944299core:FurnitureFittingsToolsEquipment2025-01-3104944299core:FurnitureFittingsToolsEquipment2025-02-012026-01-3104944299core:FurnitureFittingsToolsEquipment2026-01-31

ALAN CHALMERS (CHEMISTS) LIMITED

Registered Number
04944299
(England and Wales)

Unaudited Financial Statements for the Year ended
31 January 2026

ALAN CHALMERS (CHEMISTS) LIMITED
Company Information
for the year from 1 February 2025 to 31 January 2026

Director

JODA, Mustafa Tahsin Abed-Ali

Registered Address

The Martin Pharmacy
6 Baylis Parade Oatlands Drive
Slough
SL1 3LF

Registered Number

04944299 (England and Wales)
ALAN CHALMERS (CHEMISTS) LIMITED
Balance Sheet as at
31 January 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets419,5996,860
19,5996,860
Current assets
Stocks555,63292,077
Debtors61,031,353334,632
Cash at bank and on hand147,673253,113
1,234,658679,822
Creditors amounts falling due within one year7(608,270)(315,619)
Net current assets (liabilities)626,388364,203
Total assets less current liabilities645,987371,063
Provisions for liabilities8(4,900)(1,686)
Net assets641,087369,377
Capital and reserves
Called up share capital1,0001,000
Profit and loss account640,087368,377
Shareholders' funds641,087369,377
The financial statements were approved and authorised for issue by the Director on 21 October 2026, and are signed on its behalf by:
JODA, Mustafa Tahsin Abed-Ali
Director
Registered Company No. 04944299
ALAN CHALMERS (CHEMISTS) LIMITED
Notes to the Financial Statements
for the year ended 31 January 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery25
Fixtures and fittings25
Office Equipment25
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss. Work in progress is valued using the percentage of completion method and values are calculated using the lower of cost and estimated selling price less costs to complete and sell. When stocks are sold, the carrying amount of those stocks is recognised as an expense within cost of sales. This takes place in the same period that the associated revenue is recognised.
2.Average number of employees

20262025
Average number of employees during the year1213
3.Intangible assets
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Office Equipment

Total

££££
Cost or valuation
At 01 February 256,5898,8967,54823,033
Additions10,986-4,75115,737
At 31 January 2617,5758,89612,29938,770
Depreciation and impairment
At 01 February 256,0338,0962,04416,173
Charge for year1,1852001,6132,998
At 31 January 267,2188,2963,65719,171
Net book value
At 31 January 2610,3576008,64219,599
At 31 January 255568005,5046,860
5.Stocks

2026

2025

££
Other stocks55,63292,077
Total55,63292,077
6.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables427,306500
Amounts owed by group undertakings545,102-
Other debtors45,169139,749
Prepayments and accrued income13,776194,383
Total1,031,353334,632
7.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables272,752279,878
Taxation and social security65,02031,698
Other creditors270,498659
Accrued liabilities and deferred income-3,384
Total608,270315,619
8.Provisions for liabilities

2026

2025

££
Net deferred tax liability (asset)4,9001,686
Total4,9001,686
9.Directors advances, credits and guarantees
Director loan account as at year end was £54,814 Cr. (2025 : £15,000 Dr.)
10.Related party transactions
At the year end ultimate controlling party is MHA Wellness having Debit balance of £545,102 ( 2025 : NIL).